Accéder directement au contenu Accéder directement à la navigation
Article dans une revue

Targeting osteopontin suppresses glioblastoma stem-like cell character and tumorigenicity in vivo

Abstract : Osteopontin (OPN) is a secreted protein involved in most aspects of tumor progression and metastasis development. Elevated OPN expression has been reported in multiple types of cancer including glioblastoma (GBM), the highest grade and most aggressive brain tumor. GBMs contain a subpopulation of glioma-initiating cells (GICs) implicated in progression, therapeutic resistance and recurrence. We have previously demonstrated that OPN silencing inhibited GBM cell growth in vitro and in vivo. Moreover, activation of CD44 signaling upon OPN ligation has been recently implicated in the acquisition of a stem cell phenotype by GBM cells. The present study is aimed to explore OPN autocrine function using shRNA silencing strategy in GICs enriched from GBM cell lines and a human primary GBM grown in EGF and bFGF defined medium. The removal of these growth factors and addition of serum induced a significant loss of OPN expression in GICs. We showed that OPN-silenced GICs were unable to grow as spheres and this capacity was restored by exogenous OPN. Importantly, the expression of Sox2, Oct3/4 and Nanog, key stemness transcription factors, was significantly decreased in GICs upon OPN targeting. We identified Akt/mTOR/p70S6K as the main signaling pathway triggered following OPN-mediated EGFR activation in GICs. Finally, in an orthotopic xenograft mouse model, the tumorigenic potential of U87-MG sphere cells was completely abrogated upon OPN silencing. Our demonstration of endogenous OPN major regulatory effects on GICs stemness phenotype and tumorigenicity implies a greater role than anticipated for OPN in GBM pathogenesis from initiation and progression to probable recurrence.
Type de document :
Article dans une revue
Liste complète des métadonnées
Contributeur : Amandine Michel-Avella <>
Soumis le : mercredi 16 octobre 2019 - 11:18:44
Dernière modification le : mercredi 4 décembre 2019 - 11:14:05

Lien texte intégral



Virginie Lamour, Aurélie Henry, Jérôme Kroonen, Marie-Julie Nokin, Zofia von Marschall, et al.. Targeting osteopontin suppresses glioblastoma stem-like cell character and tumorigenicity in vivo. International Journal of Cancer, Wiley, 2015, 137 (5), pp.1047-1057. ⟨10.1002/ijc.29454⟩. ⟨hal-02317646⟩



Consultations de la notice